These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9873264)

  • 1. A stable reagent system for screening and identifying red blood cell irregular antibodies: application to commercial antibodies.
    Million L; Pellerin C; Marchand-Arvier M; Vigneron C
    Vox Sang; 1998; 75(4):288-97. PubMed ID: 9873264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of the membrane skeleton on the immunologic reactivity of the human red cell Rho(D) antigen.
    Paradis G; Bazin R; Lemieux R
    J Immunol; 1986 Jul; 137(1):240-4. PubMed ID: 3086450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities.
    Nordvall M; Dziegiel M; Hegaard HK; Bidstrup M; Jonsbo F; Christensen B; Hedegaard M
    Transfusion; 2009 Oct; 49(10):2070-5. PubMed ID: 19497053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening analysis of irregular antibodies from random donor population in Shaoguan area].
    Zhu JY; Lan JC; Luo HQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):630-1. PubMed ID: 17605881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the properties of human erythrocyte membranes in the presence of isoimmune antibodies].
    Gromov AE; Klimova KN; Gafur AS
    Biull Eksp Biol Med; 1984 May; 97(5):585-8. PubMed ID: 6426546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum protein media are important factors in the manual hexadimethrine bromide (polybrene) test, experience in China.
    Liu F; Hu LH
    Transfus Clin Biol; 2005 Feb; 12(1):34-7. PubMed ID: 15814291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KEMRI Hep-cell II hepatitis B surface antigen screening kit.
    Okoth FA; Kaiguri PM; Mathenge E; Tuei J; Muchiri S; Owino N; Kamau G; Kulundu J; Njuguna A; Tukei PM; Yano M; Naruse T
    East Afr Med J; 1999 Sep; 76(9):530-2. PubMed ID: 10685326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 2-column agglutination versus conventional tube technique for antibody screening.
    Abou-Jabal A; Shubeilat T; Hajjiri F
    East Mediterr Health J; 2003 May; 9(3):407-12. PubMed ID: 15751934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of red cell antibodies: current and future techniques.
    Knight RC; Poole GD
    Br J Biomed Sci; 1995 Dec; 52(4):297-305. PubMed ID: 8555784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Partially automated antigen determination and antibody detection with microtiter plates].
    Rapp C; Weisshaar C
    Beitr Infusionsther; 1993; 31():157-61. PubMed ID: 7693246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell iso-immunisation in the Wellington area of New Zealand: the case for antenatal prophylaxis.
    Tuohy JF; Sangalli M; Kim L
    Aust N Z J Obstet Gynaecol; 2004 Oct; 44(5):458-9. PubMed ID: 15387870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of irregular anti-erythrocyte antibodies using the indirect antiglobulin test in a low-ionic-strength medium. Immunohematology Group of the French Blood Transfusion Society].
    Mannessier L; Roubinet F
    Transfus Clin Biol; 1999 Jun; 6(3):174-9. PubMed ID: 10422210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obtention of a heterohybridoma for production of type IgM monoclonal antibodies against the D antigen of the Rh system].
    León-González G; Cruz C
    Invest Clin; 2007 Mar; 48(1):57-67. PubMed ID: 17432544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigen sandwiched ELISA for detection of total HIV antibodies].
    Hou J; He H; Mao P
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):43-6. PubMed ID: 12526302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies.
    Beliard R; Waegemans T; Notelet D; Massad L; Dhainaut F; Romeuf Cd; Guemas E; Haazen W; Bourel D; Teillaud JL; Prost JF
    Br J Haematol; 2008 Apr; 141(1):109-19. PubMed ID: 18279459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin.
    Nester TA; Rumsey DM; Howell CC; Gilligan DM; Drachman JG; Maier RV; Kyles DM; Matthews DC; Pendergrass TW
    Transfusion; 2004 Dec; 44(12):1720-3. PubMed ID: 15584986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transfusional therapy of hemodialyzed patient with anti-Cartwright antibodies: case report and review of the literature].
    Franchini M; Fabbian F; Piccoli PL; Gandini G; Aprili G; Loschiavo C; Lupo A
    G Ital Nefrol; 2004; 21(4):387-90. PubMed ID: 15526404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-RH1 (anti-D) alloimmunization after transfusion of platelet concentrates from RH :1 donors].
    Duboeuf S; Flourié F; Courbil R; Oriol P; Benamara A; Chartier M; Rigal E; Garraud O
    Ann Biol Clin (Paris); 2009; 67(3):353-7. PubMed ID: 19411240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.